Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
With
Merck Sharp & Dohme LLC
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Willing and able to provide written informed consent;
18 years of age and above;
Documented histopathology or cytopathology of PCa, adenocarcinoma;
Confirmed as mCRPC;
Initiated olaparib + abiraterone after site activation
You may not be if
Patients participating in a clinical trial with an investigational prostate cancer treatment within 30 days prior to olaparib initiation
Clareo Health | Real-World Clinical Experience of Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Olaparib + Abiraterone (PROceed)
